Trade ABOS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Acumen Pharmaceuticals, Inc. (ABOS) is trading at US$2.65, up 3.11% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$228.52M. Over the past 52 weeks, ABOS has traded between US$1.22 and US$3.60. On Syfe you can trade ABOS with $0 commission and add it to your watchlist.
| Previous close | US$2.57 |
|---|---|
| Market cap | US$228.52M |
| 52-week range | US$1.22 – US$3.60 |
| Volume | 889.87K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.
Year: 2021
Acumen Pharmaceuticals Exercises Option on Alzheimer's Program Using JCR's Technology
Jun 17, 5:22 PM · MT Newswires
Acumen Pharmaceuticals Nominates 2 Drug Candidates to Treat Alzheimer's Disease
Jun 16, 12:09 PM · MT Newswires
Acumen Pharmaceuticals, Inc. (ABOS) stock is trading at US$2.65, +3.11% from the previous close of US$2.57.
The market cap for Acumen Pharmaceuticals, Inc. (ABOS) stock is approximately US$228.52M.
The 52-week high for Acumen Pharmaceuticals, Inc. (ABOS) stock is US$3.60.
The 52-week low for Acumen Pharmaceuticals, Inc. (ABOS) stock is US$1.22.
Acumen Pharmaceuticals, Inc. (ABOS) does not currently pay a dividend.
Stay on top of ABOS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
